Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MDVL

MedAvail (MDVL) Stock Price, News & Analysis

MedAvail logo

About MedAvail Stock (NASDAQ:MDVL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.80
$5.95
52-Week Range
N/A
Volume
245,100 shs
Average Volume
261,432 shs
Market Capitalization
$2.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Receive MDVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedAvail and its competitors with MarketBeat's FREE daily newsletter.

MDVL Stock News Headlines

Delhi Bank Corp DWNX
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

MDVL Stock Analysis - Frequently Asked Questions

MedAvail Holdings, Inc. (NASDAQ:MDVL) released its quarterly earnings results on Monday, November, 8th. The company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.32) by $0.02. The business earned $5.79 million during the quarter. MedAvail had a negative net margin of 192.97% and a negative trailing twelve-month return on equity of 218.10%.

Based on aggregate information from My MarketBeat watchlists, some other companies that MedAvail investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), CrowdStrike (CRWD), Adobe (ADBE), Braze (BRZE) and e.l.f. Beauty (ELF).

Company Calendar

Last Earnings
11/08/2021
Today
5/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drug stores & proprietary stores
Sub-Industry
N/A
Current Symbol
NASDAQ:MDVL
Employees
279
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-47,620,000.00
Net Margins
-192.97%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$43.33 million
Price / Cash Flow
N/A
Book Value
$13.01 per share
Price / Book
N/A

Miscellaneous

Free Float
1,590,000
Market Cap
$2.91 million
Optionable
No Data
Beta
0.76
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (NASDAQ:MDVL) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners